Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Open accessThe DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
Mood disorders are common, chronic, recurrent mental illnesses that affect the lives of millions of individuals worldwide. To date, the monoaminergic systems (serotonergic, noradrenergic and dopaminergic) in the brain have received the greatest attention in neurobiological studies of mood disorders, and most therapeutics target these systems. However, there is growing evidence that the glutamatergic system is central to the neurobiology and treatment of these disorders. Here, we review data supporting the involvement of the glutamatergic system in mood-disorder pathophysiology as well as the efficacy of glutamatergic agents in mood disorders. We also discuss exciting new prospects for the development of improved therapeutics for these devastating disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This could lead to astrocyte/microglia imbalance, glutamatergic overproduction and excitotoxic neuronal damage (Sanacora et al., 2008) with impact on synapse functionality.”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Sanacora et al., 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, increased glutamate levels has been associated with mechanisms involved in stress and depression, such as neuro-inflammatory process, decreased levels of neurotrophic factors, diminished neurogenesis, and neuroplasticity impairment [116,117].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [117]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, rapidly acting antidepressants were discovered in the glutamatergic system (Berman et al., 2000;Sanacora et al., 2008).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Sanacora et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“Several classes of antidepressants as well as SSRIs are known to exert action on the glutamate system by influencing NMDA or AMPA receptor transcription (Sanacora et al., 2008).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Sanacora et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“Glia also play an important role in regulating the synthesis and reuptake of glutamate and thereby influence synaptic function and morphology16,17.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Although most patients with mood disorders receive some benefit from available treatment”
BackgroundTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Self-citationA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Self-citationEvidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043 · cited 1×
“, and is approved for the treatment of moderate to severe Alzheimer's disease, in which it has been shown to enhance cognition and minimize clinical deterioration in patients with Alzheimer's disease, vascular dementia or mixed dementi”
BackgroundMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Research works printed but not linked: 1
- Preskorn, S. et al. A placebo-controlled trial of the NR2B subunit specific NMDA antagonist CP-101,606 plus paroxetine for treatment resistant depression (TRD). Annual Conference of the American Psychological Association (San Francisco, California) 154 (2007).
Cited by
Items 901–1,000 of 1,000
Fulton, B. S. (2014) · Wiley eBooks · doi:10.1002/9781118943670.refs
Psychopharmacotherapy of Depressive Disorders
Kavakbasi, E., & Baune, B. T. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_427-1
Sequence-Based Analyses of the Goettingen Minipig Genome
Reimer, C. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6982
Janowsky, D. S. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.5960956.5960054
A KETAMIN HATÁSA A TERÁPIAREZISZTENS MAJOR DEPRESSZIÓRA
SZTE BTK, P. I., & Peszeki, N. (2017) · Psychologia Hungarica Caroliensis · doi:10.12663/psyhung.5.2017.1.3
Neurotrophic Mechanisms of Depression: Animal and Human Studies
Duman, R. S. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0027
McArthur, R. A., & Borsini, F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00033-3
Kleemann, A. (2012) · Wiley eBooks · doi:10.1002/14356007.a22_341.pub2
Clark, D. L., Boutros, N. N., & Mendez, M. F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776915.005
Kleemann, A. (2019) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.p02_p01.pub2
Kleemann, A. (2014) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.p02_p01
Vitaminlerin psikiyatrideki rolü: Bir gözden geçirme
Yılmaz, Y., Erdogan, A. R., & Hocaoğlu, Ç. (2021) · Troia Medical Journal
The Underrecognized Movement Disorders Associated With Mood Stabilizers
Badii, M., & Ondo, W. G. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197574317.003.0008
Depression: magnetic resonance spectroscopy studies (review)
Korostyshevskaya, A. M., Savelov, A. A., Abramova, V. D., & Shtark, M. B. (2022) · Translational Medicine · doi:10.18705/2311-4495-2022-9-4-20-32
Wei, Z., & Zhong, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2791522/v1
Cigognini, M. A. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-10052023-120550
Leitão, E. S. M. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-22082023-162443
Fu, Y., Zou, J., Zhao, W., Yang, H., Li, X., Sun, Y., Jiang, Z., Lin, Y., Ye, Y., Ma, C., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3319415/v1
Mechanisms of Thai medicinal plant extracts on the attenuation of glutamate-mediated neurotoxicity
Prasansuklab, A. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.156
Kiaee, N. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15825
Bases moléculaires et cellulaires des effets antidépresseurs de l'électro-convulsivothérapie (ECT)
Jonckheere, J. (2017) · theses.fr (ABES) · doi:10.70675/270841f0zf625z48a8zb1e2z6fab2d67e58b
Oemisch, M., & Seo, H. (2024) · eLife · doi:10.7554/elife.87529.2.sa3
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders
Куркин, Д. В., Morkovin, E. I., Bakulin, D. A., Gorbunova, Y. V., Ivanova, O. V., Pavlova, E. V., Зверева, В. И., Dzhavakhyan, M. A., Сергеевич, К. И., Kolosov, Y. A., et al. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412405122
REVOLUTIONIZING DEPRESSION TREATMENT: A PARADIGM SHIFT OF KETAMINE THERAPY – A SYSTEMATIC REVIEW
Kaushal, Y., GOYAL, P., & Sehgal, A. (2024) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2024v17i8.51360
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-5916-1
(2024) · Высшая школа: научные исследования · doi:10.25205/978-5-4437-1691-6-319
Effects of a single dose of psilocybin on diet-induced weight loss in obese mice
Keenan, R. J., Haque, R. T., Jin, X., Mustafa, T., Homman‐Ludiye, J., Elysee, K., Wee, Z. S., Simonds, S. E., Foldi, C. J., & Cowley, M. A. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03995-7
Raval, N. R., Smart, K. A., Angarita, G. A., Miller, R., Huang, Y. H., Krystal, J. H., Carson, R. E., Cosgrove, K., O’Malley, S. S., & Hillmer, A. T. (2025) · Addiction Biology · doi:10.1111/adb.70031
Self-citationPopper, V., Spurny‐Dworak, B., Unterholzner, J., Reed, M. B., Wechsler, T. F., Kautzky, A., Stöhrmann, P., Klöbl, M., Mühlberger, A., Frey, R., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-05734-2
Ee, A. C., Sulaiman, M. R., Akira, A., Israf, D. A., Tham, C. L., Ho, Y., & Lee, M. T. (2025) · The Natural Products Journal · doi:10.2174/0122103155366309250620070651
Mason, N. L., Mallaroni, P.-A., Szabo, A., & Ramaekers, J. G. (2025) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/g49mp_v1
New Year’s anxiety hangover? Here’s what’s happening in your brain
Reichelt, A. C. (2020) · The Conversation · doi:10.64628/aam.euv6fe9x3
Neves, G. A. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Emerging Psychiatric Medications: Exploring Novel Pharmacological Targets
Kumar, V., Sharma, P., Singh, N. N., Kumar, A., & Thakur, R. (2024) · International Journal of Pharmaceutical and Clinical Research · doi:10.5281/zenodo.14590157
"TREATMENT-RESISTANT DEPRESSION" AND USE OF INTRAVENOUS KETAMINE AND INTRANASAL ES-KETAMINE
Cuomo, A. (2021) · Use Siena air (University of Siena) · doi:10.25434/alessandro-cuomo_phd2021
Meyer Zu Schwabedissen, L. D. (2012) · Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt) · doi:10.25673/3815
Bewegungstraining bei unipolarer Depression
Brüchle, W. (2023) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-9631
Avaliação funcional do transporte de glutamato Na⁺₋ dependente em cérebro de peixe-zebra adulto
Horn, J. F. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ilokaasun, paaston sekä näiden yhdistelmän vaikutukset aivojen TrkB-signalointiin hiirillä
Järvinen, J. (2021) · Helda - University of Helsinki Institutional Repository
Zenki, K. C. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Wippel, C. (2012) · Online Publication Service of Würzburg University (Würzburg University)
PACAP-PAC1R and Hormonal Modulation of Stress and Fear Extinction Memories in Females
Velasco, E. R. (2023) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Fekete, A. (2021) · REAL-d (Hungarian Academy of Sciences)
Pagliarini, M. (n.d.) · CINECA IRIS Institutional Research information system (University of Urbino)
Pozo, M. S. (2014) · Universidad de Chile
Pilz, L. K. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Searching for Biomarkers in Anxiety : An fMRI study
Hjalmarsson, M. (2024) · DiVA (Digitala Vetenskapliga Arkivet)
Estabelecimento de modelo de depressão induzida por interferon-alfa em camundongos
dos Santos, Y. T. (2015) · Lume (Universidade Federal do Rio Grande do Sul)
Mur-Milà, E. (2024) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
NUOVE PROSPETTIVE NELLA TERAPIA DELLA DEPRESSIONE: LA KETAMINA E IL SISTEMA GLUTAMMATERGICO
MATRAIA, A. (2014) · Electronic Theses and Dissertations Repository (University of Pisa)
Garcia, C. R. L. (2013) · Americanae (AECID Library)
Sotomaior, B. B. (2018) · UFPR Digital Collection (Federal University of Paraná)
Epigenetic regulation of astrocytic dysfunction in depression and suicide
Nagy, C. (2017) · eScholarship@McGill (McGill) · doi:10.82308/48533
Neuropsychological mechanisms of ketamine antidepressant effect
Costi, S. (2025) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-wvydgvb7o
Association analysis of NOS1AP as a candidate gene for schizophrenia and bipolar affective disorder
Kramer, A. (2010) · Online Publication Service of Würzburg University (Würzburg University)
Cheung, N. (2026) · Preprints.org · doi:10.20944/preprints202601.0235.v1
Luzhou‐Flavor Baijiu Alleviates Stress‐Related Depressive‐Like Changes by NMDAR‐NO‐sGC‐cGMP Pathway
Xiong, L., Wu, Y., Huang, Z., Wang, S., Yang, P., Shen, C., Guo, H., Xiao, Y., Bu, Q., Gao, H., et al. (2026) · Food Safety and Health · doi:10.1002/fsh3.70075
Dhami, P. (2023) · TSpace (University of Toronto)
Spectroscopie RMN, des stratégies couramment utilisées en clinique vers les techniques de demain.
Mazuel, L. (2014) · theses.fr (ABES) · doi:10.70675/ccbf5eaaz6482z4734z9985z888d7ed05cee
Piétri, M. (2019) · theses.fr (ABES) · doi:10.70675/3122d414zcceez468bz8e31z83d8dba42e33
Influences de l'activateur tissulaire du plasminogène à la synapse neuronale
Varangot, A. (2021) · theses.fr (ABES) · doi:10.70675/e3a32036zfd7ez428fzaa2bz8383cd794625
A Comprehensive Review Of Approaches In In-Silico Anti-Depressant Drug Discovery
Rai, S., Kumar, P., Chitara, D., & Gupta, P. C. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.9s.81
Moisieienko, K., Asch, R., Davis, M. T., DellaGioia, N., Boster, S., Pietrzak, R. H., & Esterlis, I. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121888
Arora, N., & Dang, S. (2026) · BioNanoScience · doi:10.1007/s12668-026-02553-1
Neuroscience of Emotional Intelligence: An Integrative Narrative Review
Ali, A., Kulo, V., Al-Rumaihi, G., Sethi, A., Elnashar, M. S., Shaikh, N., & Jahangiri, F. R. (2026) · Cureus · doi:10.7759/cureus.108949
Aging affects glutamate-enriched functional networks in resting and movie-watching states
Zheng, Z., He, Y., Zhou, Y., Yuan, X., Sun, H., Wang, Z., Li, J., Luo, C., Dong, L., & Yao, D. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122019
II Student Scientific Conference "Modern Medicine: Molecular Approach to Pathology and Therapy"
Hrynzovska, A. (2026) · Ukrainian Scientific Medical Youth Journal · doi:10.32345/supplement.1.2026.45-213
Clinical effects of lamotrigine combined with duloxetine in the treatment of bipolar depression
Wang, X., Li, S., Chen, Y., Xu, G., Jiang, L., & Rao, J. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-026-01164-6
The Correlation between Thyroid Function and Mental Disorders: An Overview and Future Perspectives
Cheng, K., Zhang, Y., & Zhang, C. (2026) · Neuroendocrinology · doi:10.1159/000553189
Gaik, N., Dzierkacz, E., & Faron‐Górecka, A. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00878-y
Neurobiological correlates of treatment-resistant depression: implications for pharmacotherapy
Kot, J., Priadka, M., Ferensztajn‐Rochowiak, E., Kaliuzhna, O., Bienert, A., & Rybakowski, F. (2026) · Neuropsychiatria i Neuropsychologia · doi:10.5114/nan.2026.162406
幼若期の社会的ストレス負荷によるマウスの若年期における脳機能に関する研究
HASEGAWA, A. (2019) · Institutional Repositories DataBase (IRDB)
幼若期における心理社会的ストレス負荷によるグルタミン酸神経機能に関する研究
Yoshida, M. (2025) · Institutional Repositories DataBase (IRDB)
Iskakova, D. M., İlçe, B. Y., Kamzanova, A. T., Sitakanova, A., Hamoudi, R., & Kustubayeva, A. (2026) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2026.1904444
Nivetha, S. R., Vigneshwaran, R., Prasanna, G. L., Shivani., K., & Veeramani, M. (2024) · International Journal of Pharmacology and Clinical Research (IJPCR)
The Effect of Music on Stress Parameters in Acute Stroke
Adamou, L. (2021) · UTUPub (University of Turku)
Sulej, Z., & Zielińska, M. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1950244
BindingDB (2016) · UC San Diego · doi:10.7270/q29s1st0
BindingDB (2011) · UC San Diego · doi:10.7270/q2wq042g
BindingDB (2022) · UC San Diego · doi:10.7270/q2611419
BindingDB Entry 50000267: Synthesis and Pharmacological Characterization of C4
BindingDB (2019) · UC San Diego · doi:10.7270/q2w95cm9
BindingDB (2011) · UC San Diego · doi:10.7270/q27s7p13
Metadata
- Authors
- Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K.
- Affiliations
- Yale University (US)
- National Institutes of Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-05
- Volume
- 7
- Issue
- 5
- Pages
- 426-437
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC2715836
- OpenAlex
- W2074907255
- Cited by
- 894
- References
- 186
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 33 · 2023: 44 · 2022: 36 · 2021: 44 · 2020: 56 · 2019: 43 · 2018: 40 · 2017: 50 · 2016: 63 · 2015: 70 · 2014: 59 · 2013: 56 · 2012: 68
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (K02MH076222, Z01MH002828, Z01MH002857)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- glutamatergic system, mood disorders, antidepressants, neuroplasticity, glutamatergic agents, monoaminergic systems, rapid-acting antidepressants, drug development
- MeSH terms
- Animals, Glutamates, Humans, Psychotropic Drugs, Excitatory Amino Acid Antagonists, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.